DeepIE Ventures

DeepIE Ventures is an Irish venture capital firm based in Cork that specializes in seed-stage investments within the deep tech and life sciences sectors. Founded in 2021, the firm identifies and supports high-potential startups developing breakthrough technologies in areas such as biotechnology, medical devices, and agritech. Its portfolio features several prominent Irish biotech companies, including ArrayPatch, which is advancing microneedle-based therapeutics, and Ovagen, which pioneered germ-free egg technology for vaccine manufacturing. DeepIE Ventures provides strategic capital and operational guidance, often partnering with co-investors like Enterprise Ireland to accelerate the commercialization of scientific innovation. The firm plays a critical role in the Irish innovation ecosystem by bridging the gap between academic research and market-ready healthcare solutions.